跳至主要内容
临床试验/NCT06834022
NCT06834022Enrolling By Invitation不适用

Comparison of Neuromodulatory Treatment of Migraine Headache with Acupuncture and Transcranial Direct Current Stimulation

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年4月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
120
试验地点
1
主要终点
Number of days with migraine headache per month

研究概览

简要总结

The goal of this clinical trial is to compare effects of the treatment with acupuncture and transcranial direct current stimulation (tDCS) in patients with migraine headache. The main questions it aims to answer are:

  • is tDCS more effective than acupuncture/placebo?
  • is there any difference in venous blood inflammatory parameters (CGRP (calcitonin gene related peptide), IL (interleukine) -6, IL-8. IL-10, SAA (serum amyloid A) and ESR (erythrocyte sedimentation rate) before/after treatment?
  • could these inflammatory parameters function as biomarkers of disease and/or indicators of treatment's efficacy?

Participants will regularly fill out questionnaires (migraine diary) and their venous blood before/after treatment will be taken for analysis.

Researchers will compare the effects of sham and verus treatment of both methods before and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •4 migraine days per month
  • •no acupuncture in the past
  • •understanding of study design and ability to give informed consent

排除标准

  • •severe psychiatric disorders
  • •pacemaker
  • •status post brain surgery with open skull
  • •brain stimulators
  • •metal implants
  • •biologic drugs
  • •pregnancy

研究组 & 干预措施

Sham Acupuncture

Placebo Comparator

Patients receive sham acupuncture (skin remains intact, away from standard acupuncture points)

干预措施: Acupuncture (Procedure)

Verus Acupuncture

Active Comparator

Patients receive acupuncture treatment over semistandardized acupuncture points for migraine headache.

干预措施: Acupuncture (Procedure)

Sham tDCS

Placebo Comparator

Device will provide only placebo stimulation (study mode)

干预措施: Transcranial direct current stimulation (Device)

verus tDCS

Active Comparator

Device will stimulate with direct current (study mode)

干预措施: Transcranial direct current stimulation (Device)

结局指标

主要结局

Number of days with migraine headache per month

时间窗: 4 months

Evaluation of migraine days before study, at 1 nad 3 months after comleted therapy.

次要结局

  • Change of inflammatory parameters(4 months)
  • Severity of migraine headache(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alenka Spindler-Vesel

MD, PhD, Principal Investigator

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验